海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
219件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Physical Exercise as an Additional Treatment for Alzheimer Disease
- Alzheimer Disease
- Brazil
- 2012-01-12
Not recruiting
- Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)
- Primary Hypercholesterolemia;Mixed Dyslipidemia
- Argentina, Australia, Brazil, Bulgaria, Chile, Colombia, Czech Republic, France, Germany, Hungary, India, Israel, Italy, Mexico, Netherlands, New Zealand, Peru, Philippines, Poland, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2010-10-25
Authorised
- A Study of Gantenerumab in Patients With Prodromal Alzheimer's Disease
- Prodromal Alzheimer’s Disease MedDRA version: 20.0 Level: LLT Classification code 10066571 Term: Progression of Alzheimer's disease System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Turkey, United Kingdom
- 2010-08-27
Recruiting
- Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease
- Alzheimer's Disease;Apathy
- Brazil
- 2013-06-18
Recruiting
- A 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects With Early Alzheimer's Disease
- Alzheimer's Disease
- Argentina, Australia, Austria, Bulgaria, Canada, Czech Republic, Czechia, France, Germany, Greece, Japan, Korea, Republic of, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, Spain, Sweden, United Kingdom, United States
- 2016-11-03
Not Recruiting
- Effects of Physical Exercise on Cognitive and Motor Functions in Alzheimer's Disease
- Alzheimer Disease; Dementia in Alzheimer's Disease; Aged F00 C10.228.140.380.100 M01.060.116.100;F00-F99;C10.228.140.380.100;M01.060.116.100
- Brazil
- 2018-04-30
Not recruiting
- An Open-Label Crenezumab Study in Patients With Alzheimer's Disease
- Alzheimer's Disease
- Australia, Belgium, Canada, Costa Rica, Croatia, Czechia, Denmark, Finland, France, Germany, Hong Kong, Hungary, Italy, Korea, Republic of, Lithuania, Mexico, Poland, Portugal, Russian Federation, South Africa, Spain, Sweden, Turkey, Ukraine, United Kingdom, United States
- 2018-03-15
Not recruiting
- Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
- Alzheimer's Disease;Alzheimer's Disease;Alzheimer's Disease;Alzheimer's Disease
- Bulgaria, Chile, Czech Republic, Germany, Korea, Republic of, Russian Federation, Slovakia, United Kingdom
- 2009-11-05
Not recruiting
- A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
- Moderate to Severe Alzheimer
- Chile, United Kingdom
- 2009-08-06
Not recruiting
- A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
- Alzheimer's Disease
- Canada, Chile, Czech Republic, United States
- 2009-06-29
